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Experimental section
Neuroprotective effects of compounds 1-4. Compounds 1-4 were tested for neuroprotective effects against rotenone-induced injury in PC12 cells using an MTT assay. The PC12 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 5% horse serum, 5% fetal bovine serum. Then, 100 μl cells with an initial density of 5×10 4 cells/ml were seeded in each well of a poly-L-lysine coated 96-well culture plates and precultured for 24h at 37 °C under a 5% CO 2 atmosphere.
Afterwards, the medium were placed by different fresh medium including the control (complete medium), the model (complete medium with 4 μM rotenone) and the sample (complete medium with 4 μM rotenone and 1 μM test samples), and the cells were cultured for 48 h. Then, 10 μl MTT (0.5 mg/ml) was added to each well. After incubation for 4 h, the medium was removed and 100 μl DMSO was added to dissolve formazan crystals. The optical density ( 
